Christina Vorvis receives award for research on pancreatic cancer
Christina Vorvis, BSc, a member of the Dr. Iliopoulos laboratory, was awarded a prestigious PhD student award for her research on pancreatic cancer. Her research work and presentation was selected as the best between the PhD candidates in the UCLA Molecular, Cellular and Integrative Physiology (MCIP) PhD program. Christina's research presentation was on "Transcriptomic and CRISPR/Cas9 technologies Reveal FOXA2 as a Tumor Suppressor Gene in Pancreatic Cancer." She received the award during the MCIP PhD program's annual retreat at The Hollywood Roosevelt Hotel on February 20, 2016.
Breakthrough experimental therapy for colon cancer and chronic IBD
Health Canal reported July 31, 2015 on UCLA researchers finding a new chemical inhibitor able to block a molecule involved in the transmission of genetic information. UCLA scientists hope the research will assist physicians in treating colon cancer and inflammatory bowel disease. Dr. Dimitrios Iliopoulos, associate professor of medicine in the division of digestive diseases and member of UCLA's Jonsson Comprehensive Cancer Center Gene Regulation Program, was quoted.
Breakthrough experimental therapy for colon cancer and chronic IBD
IBD July 28, 2015 and MedicalXpress July 29, 2015 reported on UCLA researchers finding a new chemical inhibitor able to block a molecule involved in the transmission of genetic information. UCLA scientists hope the research will assist physicians in treating colon cancer and inflammatory bowel disease. Dr. Dimitrios Iliopoulos, associate professor of medicine in the division of digestive diseases and member of UCLA's Jonsson Comprehensive Cancer Center Gene Regulation Program, was quoted.
Can antibiotics prevent deaths from stomach cancer?
Dimitrios Iliopoulos, PhD, MBA, director of the UCLA Center for Systems Biomedicine, was quoted in a July 22, 2015 Forbes/Pharma & Healthcare article on a new report that claims taking antibiotics for a common bacteria, Helicobacter pylori, reduces the occurrence of gastric cancer.
